IL-13Rα2-targeted CAR T cells show promise in patients with recurrent high-grade gliomas.
Nat Rev Clin Oncol
; 21(5): 335, 2024 May.
Article
in En
| MEDLINE
| ID: mdl-38514882
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Brain Neoplasms
/
Immunotherapy, Adoptive
/
Interleukin-13 Receptor alpha2 Subunit
/
Receptors, Chimeric Antigen
/
Glioma
Limits:
Humans
Language:
En
Journal:
Nat Rev Clin Oncol
Journal subject:
NEOPLASIAS
Year:
2024
Document type:
Article
Country of publication: